Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1469693, 11 pages
http://dx.doi.org/10.1155/2016/1469693
Research Article

Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways

1Department of Urology, The 3rd Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510630, China
2Department of Cell Biology & Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, Guangdong Provincial Key Laboratory of Bioengineering Medicine, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong 510632, China
3Department of Kidney Transplantation, The 3rd Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510630, China

Received 21 May 2016; Revised 21 July 2016; Accepted 14 August 2016

Academic Editor: Domenico D’Arca

Copyright © 2016 Yun Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Gundem, P. Van Loo, B. Kremeyer et al., “The evolutionary history of lethal metastatic prostate cancer,” Nature, vol. 520, no. 7547, pp. 353–357, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Di, J. Pang, Q. P. Sun et al., “Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-κB in prostate cancer cells,” Molecular Biology Reports, vol. 37, no. 4, pp. 1849–1855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-M. Di, J. Zhou, X.-L. Zhou et al., “Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer,” Archives of Medical Research, vol. 40, no. 4, pp. 268–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. de la Taille, M. A. Rubin, M.-W. Chen et al., “β-Catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells,” Clinical Cancer Research, vol. 9, no. 5, pp. 1801–1807, 2003. View at Google Scholar · View at Scopus
  5. L. W. Runnels, L. Yue, and D. E. Clapham, “TRP-PLIK, a bifunctional protein with kinase and ion channel activities,” Science, vol. 291, no. 5506, pp. 1043–1047, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. L. W. Runnels, “TRPM6 and TRPM7: a Mul-TRP-PLIK-cation of channel functions,” Current Pharmaceutical Biotechnology, vol. 12, no. 1, pp. 42–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. W.-L. Chen, A. Barszczyk, E. Turlova et al., “Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion,” Oncotarget, vol. 6, no. 18, pp. 16321–16340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Wang, Q.-J. Liao, Y. Zhang et al., “TRPM7 is required for ovarian cancer cell growth, migration and invasion,” Biochemical and Biophysical Research Communications, vol. 454, no. 4, pp. 547–553, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Middelbeek, A. J. Kuipers, L. Henneman et al., “TRPM7 is required for breast tumor cell metastasis,” Cancer Research, vol. 72, no. 16, pp. 4250–4261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sun, S. Selvaraj, A. Varma, S. Derry, A. E. Sahmoun, and B. B. Singh, “Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels,” Journal of Biological Chemistry, vol. 288, no. 1, pp. 255–263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Sun, P. Sukumaran, A. Varma, S. Derry, A. E. Sahmoun, and B. B. Singh, “Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1843, no. 9, pp. 1839–1850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-M. Lin, J.-M. Ma, L. Zhang et al., “Inhibition of transient receptor potential melastain 7 enhances apoptosis induced by TRAIL in PC-3 cells,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 10, pp. 4469–4475, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Zhou, S. Guo, Z. Xiong, and M. Liu, “Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy,” Expert Opinion on Therapeutic Targets, vol. 18, no. 10, pp. 1177–1196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Liu, K. Inoue, T. Leng, S. Guo, and Z.-G. Xiong, “TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways,” Cellular Signalling, vol. 26, no. 12, pp. 2773–2781, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. W.-L. Chen, E. Turlova, C. L. F. Sun et al., “Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways,” Marine Drugs, vol. 13, no. 4, pp. 2505–2525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. E. Suntres, J. Coccimiglio, and M. Alipour, “The bioactivity and toxicological actions of carvacrol,” Critical Reviews in Food Science and Nutrition, vol. 55, no. 3, pp. 304–318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Parnas, M. Peters, D. Dadon et al., “Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels,” Cell Calcium, vol. 45, no. 3, pp. 300–309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Du, J. Xie, Z. Zhang et al., “TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation,” Circulation Research, vol. 106, no. 5, pp. 992–1003, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. X. L. Mei, Y. Yang, Y. J. Zhang et al., “Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo,” American Journal of Cancer Research, vol. 5, no. 11, pp. 3311–3324, 2015. View at Google Scholar
  20. Z. Shi, A. K. Tiwari, S. Shukla et al., “Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance,” Cancer Research, vol. 71, no. 8, pp. 3029–3041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Luo, Q.-W. Jiang, J.-Y. Wu et al., “Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer,” Oncotarget, vol. 6, no. 26, pp. 22564–22574, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Luo, J. Y. Wu, G. L. Hou, M. H. Lu, Z. Shi, and J. M. Di, “ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer,” American Journal of Translational Research, vol. 8, no. 2, pp. 670–679, 2016. View at Google Scholar
  23. J. M. Liu, F. Pan, L. Li et al., “Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation,” Biochemical and Biophysical Research Communications, vol. 437, no. 1, pp. 87–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Shi, H. R. Park, Y. Du et al., “Cables1 complex couples survival signaling to the cell death machinery,” Cancer Research, vol. 75, no. 1, pp. 147–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Shi, A. K. Tiwari, S. Shukla et al., “Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478,” Biochemical Pharmacology, vol. 77, no. 5, pp. 781–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L.-H. Gong, X.-X. Chen, H. Wang et al., “Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 906804, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-G. Qiu, Y.-J. Zhang, Y. Li et al., “Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter,” Oncotarget, vol. 6, no. 17, pp. 15494–15509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-P. Wang, X.-Y. Pu, and X.-H. Wang, “Distribution profiles of transient receptor potential melastatin-related and vanilloid-related channels in prostatic tissue in rat,” Asian Journal of Andrology, vol. 9, no. 5, pp. 634–640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Taylor, P. M. Jenner, and W. I. Jones, “A comparison of the toxicity of some allyl, propenyl, and propyl compounds in the rat,” Toxicology and Applied Pharmacology, vol. 6, no. 4, pp. 378–387, 1964. View at Publisher · View at Google Scholar · View at Scopus
  30. S. K. Martin, M. Kamelgarn, and N. Kyprianou, “Cytoskeleton targeting value in prostate cancer treatment,” American Journal of Clinical and Experimental Urology, vol. 2, no. 1, pp. 15–26, 2014. View at Google Scholar
  31. S. Stelloo, J. Sanders, E. Nevedomskaya et al., “mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma,” Oncotarget, vol. 7, no. 22, pp. 32916–32925, 2016. View at Publisher · View at Google Scholar
  32. L. Moro, A. A. Arbini, E. Marra, and M. Greco, “Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2,” International Journal of Oncology, vol. 48, no. 6, p. 2722, 2016. View at Publisher · View at Google Scholar
  33. M. Yu, C. Huang, Y. Huang, X. Wu, X. Li, and J. Li, “Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts,” Inflammation Research, vol. 62, no. 11, pp. 961–970, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Meng, C. Cai, J. Wu et al., “TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway,” Cancer Letters, vol. 333, no. 1, pp. 96–102, 2013. View at Publisher · View at Google Scholar · View at Scopus